TriSalus Life Sciences Warrant
TLSIW
21 hedge funds and large institutions have $3.33M invested in TriSalus Life Sciences Warrant in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.95% less ownership
Funds ownership: 10.78% → 9.84% (-0.95%)
5% less funds holding
Funds holding: 22 → 21 (-1)
11% less capital invested
Capital invested by funds: $3.72M → $3.33M (-$391K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$50.3K |
| 2 |
ACM
Alpha Capital Management
Austin,
Texas
|
+$22.2K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$13.5K |
| 4 |
FVWA
Foster Victor Wealth Advisors
Greenville,
South Carolina
|
+$8.64K |
| 5 |
Walleye Capital
New York
|
+$3.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$159K |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$112K |
| 3 |
CF
Cantor Fitzgerald
New York
|
-$73.4K |
| 4 |
Jane Street
New York
|
-$20.4K |
| 5 |
KL
KIM LLC
Wichita,
Kansas
|
-$9.98K |
TLSIW Hedge Fund Activity: Q1 2024 in Review
21 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q1 2024, worth a combined $3.33M — down 11% from $3.72M a quarter earlier.
Fund positioning in TLSIW was balanced in Q1 2024: 3 funds opened new positions, 3 closed out, 5 added to existing stakes and 4 trimmed.
The largest buyer was Cowen and Company, opening a new position worth an estimated $50.3K. The largest seller was Point72 Asset Management, exiting entirely with an estimated $159K sold.
- 21 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q1 2024, down from 22 in Q4 2023.
- Funds reported $3.33M of TriSalus Life Sciences Warrant stock for Q1 2024, down 11% quarter-over-quarter.
- 3 funds opened new TriSalus Life Sciences Warrant positions in Q1 2024 and 3 closed out, a net change of 0 holders.
- The largest TriSalus Life Sciences Warrant buyer in Q1 2024 was Cowen and Company, an estimated $50.3K added.
- The largest TriSalus Life Sciences Warrant seller in Q1 2024 was Point72 Asset Management, an estimated $159K sold.
Based on aggregated 13F filings for Q1 2024.